Binimetinib, used with encorafenib, is for treating melanoma with BRAF V600E/K mutations. It’s like a block for the MEK enzyme, which is part of a big signaling system in cells. You get this drug in 15 mg tablets, and the usual amount is two of them, twice a day.
So, you take three tablets, whether you eat or not. Each bottle has 84 of those tablets. The MEK pathway helps cells multiply.
Binimetinib, by blocking it, helps keep cancer cells from growing if they have certain BRAF changes. Make sure you take it exactly like the doctor said, and don’t take more than you should to prevent any problems.
Reviews
There are no reviews yet.